Evidence map›Paper›PMID 36451984›Full record

ArticleThe Pan African medical journal2022

[Predictors of hepatic encephalopathy in patients with severe acute liver injury].

Amal Khsiba, Samir Bradai, Moufida Mahmoudi, Asma Ben Mohamed, Mouna Medhioub, Lamine Hamzaoui, Mohamed Mousadek Azouz

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Amal KhsibaGastroenterology Department, Mohamed Tahar Maamouri Hospital, Nabeul, Tunisia.
Samir BradaiGastroenterology Department, Mohamed Tahar Maamouri Hospital, Nabeul, Tunisia.
Moufida MahmoudiGastroenterology Department, Mohamed Tahar Maamouri Hospital, Nabeul, Tunisia.
Asma Ben MohamedGastroenterology Department, Mohamed Tahar Maamouri Hospital, Nabeul, Tunisia.
Mouna MedhioubGastroenterology Department, Mohamed Tahar Maamouri Hospital, Nabeul, Tunisia.
Lamine HamzaouiGastroenterology Department, Mohamed Tahar Maamouri Hospital, Nabeul, Tunisia.
Mohamed Mousadek AzouzGastroenterology Department, Mohamed Tahar Maamouri Hospital, Nabeul, Tunisia.
Hôpital Sahloul · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: severe acute liver injury (SALI) formerly known as severe acute hepatitis is an acute inflammation of the liver with markers of liver injury (elevated transaminases) and signs of hepatocellular failure (jaundice and INR greater than 1.5) according to the latest definition of the European Association for the Study of the Liver (EASL). An important prognostic factor in SALI is the development of hepatic encephalopathy (HE) and thus its progression to acute liver failure (ALF), formerly known as acute severe hepatitis. The purpose of this study is to investigate factors predicting the development of hepatic encephalopathy during SALI. Methods: we conducted a retrospective study of patients treated for SALI between January 2000 and December 2019. We divided patients into two groups depending on whether hepatic encephalopathy occurred. We performed an analytical study comparing the two groups according to their epidemiological, biological and evolutionary data. Results: data from the medical records of fifty-nine patients were collected. A virus was the most frequent cause (63%). Hepatic encephalopathy occurred in 15 patients (25.4%). Factors predicting the development of HE in univariate analysis were a delay in consultation of more than 9 days, an INR level of more than 2.45, a bilirubin level of more than 230 μmol/l, creatinine greater than 60.5 μmol/l, urea greater than 5.5 mmol/l and MELD score greater than 26.5 (p=0.023, p=0.017, p=0.0001, p=0.049, p=0.0001, p=0.0001 respectively). Autoimmune hepatitis and an undetermined cause were associated with the development of HE (p=0,003 and p=0,044, respectively). In multivariate analysis, autoimmune aetiology and a urea level above 5.5 mmol/l were significantly associated with the occurrence of HE. No statistically significant differences were found between the two groups with regard to age, sex and diabetes. Conclusion: SALI is a rare disease, mainly due to a virus in our country. Predictive factors of HE are important for early identification of patients at risk of adverse outcomes.

Indexed as

Hepatic EncephalopathyHepatitis, AutoimmuneHumansRetrospective StudiesUreaUreaacute liver failurehepatic encephalopathyprognosisSevere acute liver injury

Identifiers

PMID36451984
PMCPMC9664508
OpenAlexW4310591446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.